The Valley Desk

NCT03157128 · Interventional trial

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Any Solid Tumor, Colon Cancer, Medullary Thyroid Cancer, Non-Small Cell Lung Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov